Pfizer Inc. (PFE)
Analysis of Revenues
Revenue Recognition Accounting Policy
Pfizer records revenues from product sales when there is a transfer of control of the product from Pfizer to the customer. Pfizer determines transfer of control based on when the product is shipped or delivered and title passes to the customer.
Source: 10-K (filing date: 2019-02-28).
Revenues as Reported
Pfizer Inc., Income Statement, Revenues
US$ in millions
|12 months ended||Dec 31, 2018||Dec 31, 2017||Dec 31, 2016||Dec 31, 2015||Dec 31, 2014|
|Pfizer Innovative Health (IH)||33,426||31,422||29,197||26,757||24,005|
|Pfizer Essential Health (EH)||20,221||21,124||23,627||22,094||25,402|
|Certain significant items||—||—||—||—||198|
|Revenues||Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).||Pfizer Inc.’s revenues declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.|